© 2022 MJH Life Sciences and Contagion Live. All rights reserved.
© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
Andrew J. Hale, MD, is an infectious disease physician at the University of Vermont Medical Center and an assistant professor of medicine at Larner College of Medicine at the University of Vermont in Burlington.
September 20, 2022
Here is a review of using this therapy in this patient population.
December 16, 2021
August 17, 2021
June 08, 2020
This is one of the first studies examining the effect of a dedicated postsplenectomy comprehensive clinic.
October 08, 2019
One promising proposal to greatly increase access to DAA HCV therapy is to keep this treatment with appropriately trained PCPs, in contrast with referring patients to infectious disease, gastroenterology, or hepatology subspecialists.
May 29, 2019
This In the Literature piece explores if we can mitigate some of the adverse reactions that are being seen in obese patients who receive vancomycin through AUC-dosing.
To Eliminate Hepatitis by 2030, Hepatitis B Needs More Attention
Monkeypox in Children: Uncommon but Potentially Concerning
CDC Finds Recovery Common From Rare Vaccine-Related Myocarditis
September's Top 5 Infectious Disease Stories